TCL Archive In Brief: Clarke, Einstein Lead ACCC; Changes At CCSG, Cohen Leaves USC For Childhood Foundation April 17, 1992
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
